Filing Summary
Filing entity: Avista Public Acquisition Corp. II, although the request metadata identifies Omniab, Inc. The filing is an 8-K reporting the pricing and closing of a special purpose acquisition company IPO. The filing date is August 12, 2021, with the earliest reported event dated August 9, 2021.
Business Context and Reporting Period
The company is a Cayman Islands SPAC formed to pursue an initial business combination. It reported the pricing of its IPO on August 9, 2021, and consummation of the IPO on August 12, 2021. No operating business, revenue, or comparable reporting-period financial statements are presented.
Key Financial Metrics and Capitalization
- IPO: 23,000,000 units sold at $10.00 per unit, generating $230.0 million of gross proceeds. The total included 3,000,000 units issued upon full exercise of the underwriters’ over-allotment option.
- Unit structure: Each unit consisted of one Class A ordinary share and one-third of a redeemable warrant. Each whole warrant is exercisable at $11.50 per share, subject to adjustment.
- Private placement: 8,233,333 warrants sold to the sponsor at $1.50 per warrant, generating $12.35 million of gross proceeds.
- Trust account: $235.75 million of IPO proceeds and a portion of the private placement proceeds were deposited into a U.S.-based trust account at JPMorgan Chase Bank, N.A., with Continental Stock Transfer & Trust Company as trustee.
- Revenue, profit, cash flow, margins, and debt: The filing does not provide operating financial results, cash-flow metrics, margins, or debt balances.
Material Changes and Terms
- The company adopted amended and restated memorandum and articles of association in connection with the IPO.
- It entered into warrant, trust, registration rights, private placement, administrative services, letter, indemnity, and forward purchase agreements, principally dated August 9, 2021.
- Private placement warrants generally have transfer restrictions while held by the sponsor or permitted transferees and include registration rights.
Outlook, Risks, and Contingencies
- Trust-account funds are generally restricted until the earliest of completion of the initial business combination, certain shareholder-approved amendments followed by redemptions, or redemption of all public shares if no business combination is completed within 18 months after the IPO closing.
- Interest earned in the trust account may be released to pay taxes if the funds are held in an interest-bearing account.
- The filing does not identify a target, provide business-combination guidance, or establish an operating forecast.
- Investors face the usual SPAC risks, including the possibility that no business combination is completed, public-share redemptions, dilution from warrants and sponsor securities, and loss of investment opportunity if the transaction deadline expires.
Investor Verification Items
- Confirm the correct issuer: the filing identifies Avista Public Acquisition Corp. II, not Omniab, Inc.
- Verify the IPO closing date, because the filing references August 9 for pricing and agreements but August 12 for consummation and the signature date.
- Review the warrant agreement for exercise, adjustment, redemption, and other terms.
- Review the trust agreement and governing documents for redemption rights and the 18-month business-combination deadline.
- Assess dilution from the 23.0 million public units, 8.233 million private placement warrants, and any forward purchase arrangements.